Andere talen NeoGenomics, Inc.

Aandelen

NEO

US64049M2098

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 22-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
13,42 ^USD	-0,81%		-2,40%	-17,06%

18/04	NeoGenomics, Inc. Kondigt promoties aan in senior management	CI
18/04	NeoGenomics, Inc. kondigt aan dat de positie van Vishal Sikri, President, Advanced Diagnostics, komt te vervallen	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

NeoGenomics Announces Senior Leadership Promotions	18/04
NeoGenomics, Inc. Announces Senior Leadership Promotions	18/04
NeoGenomics, Inc. Announces Eliminates of Position of Vishal Sikri, President, Advanced Diagnostics	18/04
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024	09/04
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting	27/03
NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report	20/03
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference	04/03
NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference	01/03
Traders Await Fed Minutes, Nvidia Earnings as US Equity Futures Drop Pre-Bell	21/02
NeoGenomics Swings to Q4 Adjusted Earnings, Revenue Rises; Issues 2024 Guidance	21/02
NeoGenomics: Q4 Earnings Snapshot	20/02
NeoGenomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/02
Earnings Flash (NEO) NEOGENOMICS Reports Q4 EPS $0.03, vs. Street Est of $-0.03	20/02
Earnings Flash (NEO) NEOGENOMICS Reports Q4 Revenue $155.6M, vs. Street Est of $152.5M	20/02
NeoGenomics Reports Fourth Quarter and Full Year 2023 Results	20/02
NeoGenomics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	20/02
NeoGenomics, Inc. Provides Earnings Guidance for the Year 2024	20/02
NeoGenomics Signs Working with Cancer Pledge in Support of Employees	01/02
Pomerantz Law Firm Investigates Claims on Behalf of Investors of NeoGenomics, Inc. - NEO	31/01
NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024	30/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen NeoGenomics, Inc.

Aandelen

NEO

US64049M2098

Andere talen

Filters